Documents created by Pfizer for the meeting with the Food and Drug Administration advisory panel, as Pfizer seeks approval for emergency use of their COVID-19 vaccine are seen on Thursday, Dec. 10, 2020. The FDA panel functions like a science court. During the scheduled daylong session, it was expected to debate and pick apart the data on whether the vaccine is safe and effective enough to be cleared for emergency use. (AP Photo/Jon Elswick)Русскоязычная пресса